Can a brain scan predict Cancer's return?
NCT ID NCT05222269
Summary
This study aimed to see if a special type of PET scan, using a tracer called [68Ga]Ga-PentixaFor, could predict how well patients with primary or isolated secondary brain lymphoma would respond to chemotherapy. The goal was to check if a scan taken partway through treatment could accurately forecast whether the cancer would stay away or come back. The study was terminated early after enrolling only one patient.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CNS LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Aalborg
Aalborg, 9000, Denmark
-
University Hospital CHU Nantes
Nantes, 44093, France
Conditions
Explore the condition pages connected to this study.